Deep Brain Stimulation for Movement Disorders - Grenoble
Deep Brain Stimulation for Movement Disorders
Grenoble, France – September 10-11, 2015
More than 100,000 patients worldwide have been treated by deep brain stimulation (DBS) for a drug refractory movement disorder. General neurologists will be increasingly confronted with the management of these patients, who suffer from chronic neurological conditions, such as Parkinson's disease, and require lifelong care. This course will instruct general neurologists on how to identify the cause of clinical problems in DBS-treated patients which result from either the underlying disease, inappropriate adjustment of medication and stimulation, or stimulation itself. The presentations will also discuss the selection criteria for surgery, which is necessary to consult appropriate candidates and to refer these patients to surgical centers.
At the conclusion of this activity, participants should be able to accomplish the following:
- Provide an overview of the selection process of candidates for deep brain stimulation in movement disorders – especially Parkinson’s disease, dystonia and tremor
- Outline the efficacy and associated risks for DBS, including understanding the different brain targets used for DBS and their effects on specific symptoms
- Discuss the different electrical parameters that can be adjusted for DBS and outline their biological effect
- Describe the strategies for adjustment of medication and DBS settings, especially for Parkinson’s disease, and discuss common therapy associated problems, hardware related problems, and troubleshooting strategies
- Understand the role of the neurologist in long-term management of DBS patients
This course is intended for movement disorder specialists, general neurologists and trainees who want to become more involved in the selection or postoperative management of patients with movement disorders (tremor, dystonia, Parkinson’s disease, etc.) treated by deep brain stimulation surgery.
The International Parkinson and Movement Disorder Society is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.
The Deep Brain Stimulation for Movement Disorders course is designated for a maximum of 8 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.